跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-FINASTERIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-FINASTERIDE
Authorized
STANDARD
M-FINASTERIDE
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6360b5c8f1d1c95d
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
6360b5c8f1d1c95d
Drug Approval Canada Name
M-FINASTERIDE
Product Name
M-FINASTERIDE
Status
Marketed
Status Date
2022-10-07
Original Market Date
2022-10-07
Din
02522489
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
92:04.00
Atc Original
G04CB01 FINASTERIDE
Atc Name
g 04 cb 01
Aig Number
0124110001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
FINASTERIDE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6360b5c8f1d1c95d
Type
Standard
Back to Health Canada Approvals